Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
TriVirum is a medical device company that uses edge semiconductor and signal processing technology to build new, innovative medical devices.
Recourse is a experiential skills development platform allows clinicians to immediately put theory into practice .
Gigged AI is an artificial intelligence-powered platform designed for swiftly sourcing tech talent.
Kinsetsu provides intelligent tracking solutions to help organisations automate and optimise tasks and services.
Global Surface Intelligence is an Edinburgh-based earth observation and artificial-intelligence-as-a-service provider
Machines With Vision is transforming the maintenance of linear infrastructure using millimetre-accurate mapping.
UK-based compressor manufacturing company.
Cyan Forensics sells software to help police, social media, and cloud providers find & block harmful content from pedophiles and terrorists.
We help healthcare reduce risk & cost by monitoring, managing and engaging patients at home.
QikServe is the enterprise platform for guest self-service in hospitality.
Censo Bio is a specialist CRO with exceptional skill in complex cell biology, specializing in human neurodegenerative, neuroinflammatory.
Mark to Market helps finance professionals perform accurate, auditable private company valuations.
Beloved supplies natural date ingredients and offers innovative solutions aiming at sugar reduction.
BondMason is a specialist in UK property investing.
Q Spine Ltd. designs, manufactures and distributes medical devices for the spinal market.
ForSpills offers absorbent powder for liquid and semi-liquid spills.
Covec manufactures and supplies textiles made from yarns.
Par Equity has invested in 65 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Par Equity's top investment sectors include Health Care, Medical Device, Software, Manufacturing, Sensor. The firm invests across 44 different industry categories.
Among tracked funding rounds, Current Health received $43.0M in a Series B round. Par Equity's total known invested capital is $261.5M.
Par Equity's average investment size is $5.4M across its portfolio of 65 companies.
Recent Par Equity portfolio additions include TriVirum, Re:course, GIGGED LTD, Kinsetsu, Global Surface Intelligence. These companies were founded in 2020 or later.